^
CANCER:

Basal Cell Carcinoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
No biomarker
Basal Cell Carcinoma
fluorouracil topical
Sensitive
:
A1
No biomarker
Basal Cell Carcinoma
vismodegib
Sensitive
:
A1
No biomarker
Basal Cell Carcinoma
imiquimod
Sensitive
:
A1
No biomarker
Basal Cell Carcinoma
sonidegib
Sensitive
:
A1
No biomarker
Basal Cell Carcinoma
cemiplimab
Sensitive
:
A1
No biomarker
Basal Cell Carcinoma
celecoxib
Resistant
:
A2
SMO mutation
Basal Cell Carcinoma
vismodegib
Resistant
:
B
PD-L1 expression
Basal Cell Carcinoma
pembrolizumab
Sensitive
:
C1
TMB-H
Basal Cell Carcinoma
Immunotherapy
Sensitive
:
C3
GLI1 overexpression
Basal Cell Carcinoma
vismodegib
Resistant
:
C3
GAS1 underexpression
Basal Cell Carcinoma
vismodegib
Sensitive
:
C3
SMO W535L
Basal Cell Carcinoma
sonidegib
Resistant
:
C4
SMO Q477E
Basal Cell Carcinoma
sonidegib
Resistant
:
C4
SMO D473H
Basal Cell Carcinoma
sonidegib
Resistant
:
C4
SMO S533N
Basal Cell Carcinoma
sonidegib
Resistant
:
C4
SMO D473G
Basal Cell Carcinoma
sonidegib
Resistant
:
C4
PTCH1 1504-1G>T + TMB-H
Basal Cell Carcinoma
nivolumab + vismodegib
Sensitive
:
C4